Global Cancer Technology on Netcapital

GCT’s lead cancer technology is its remote-controlled cancer drug delivery platform.

Raise to date: $4,618

Reporting Date: 11/10/2019

Key Stats

Minimum Raise

$10,000

Maximum Raise

$107,000

Likelihood of Max Unlikely
Start Date

10/22/2019

Stop Date

11/19/2019

Days Remaining

7

Security Type

Common Stock

Investment Minimum

$1

Deal Type

No Review


Investment Summary

Status

Active

# of Investors

Not Known

% of Minimum Raised

46%

% of Maximum Raised

4%

Dollars Per Day to Reach Max

$14,626

DPD* Committed

$243

DPD* Category

$130

DPD* All Companies

$1,351

Kingscrowd Momentum

$4,618

Total Dollars Raised

Commitments

Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

Global Cancer Technology, with a post-money valuation of $11.6 million, is raising funds on NetCapital. It is an emerging medical technology company that may soon revolutionize cancer therapy. The technology of Global Cancer Technology is protected by several patents and is aimed at remote-controlled cancer drug delivery. Global Cancer Technology was founded by John P. Clark. The current round of crowdfunding has a minimum target of $10,000 and a maximum target of $107,000, and the proceeds will be used for pre-clinical work, research, marketing, commercialization, and general and administrative expenses. The technology of Global Cancer Technology was developed by scientists at Moores Cancer Center UC San Diego. Using the technology, the cancer drug will be attached to a nanocrystal scintillator and delivered to the body conveniently.

INVEST NOW